19/07/201321/10/2023 HELIX BIOPHARMA CORP. ANNOUNCES EXTENSION OF 2010 WARRANT EXPIRY DATE admin 0 Comments
29/05/201321/10/2023 HELIX BIOPHARMA CORP. INITIATES ENROLLMENT FOR FOURTH COHORT IN POLISH PHASE I/II CLINICAL STUDY OF ITS LUNG CANCER DRUG CANDIDATE L-DOS47 admin 0 Comments
08/04/201321/10/2023 Helix BioPharma Corp. announces L-DOS47 scientific poster to be presented at American Association for Cancer Research Annual Meeting in Washington, DC admin 0 Comments
04/04/201321/10/2023 HELIX BIOPHARMA CORP. INITIATES ENROLLMENT FOR THIRD COHORT AND EXPANSION OF CENTRES admin 0 Comments
18/03/201321/10/2023 Helix BioPharma Corp. announces L-DOS47 scientific presentation to be made at BIT LifeScience’s 5th International Congress of Antibodies admin 0 Comments
18/03/201321/10/2023 BIT’s 5th Annual International Congress of Antibiodies Conference admin 0 Comments